
SCI — Investor Relations & Filings
SCI Pharmtech, Inc. specializes in the research, development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals. Established in 1987 and originally founded by the Swiss Siegfried Group, the company provides high-quality chemical solutions and custom manufacturing services to leading global pharmaceutical corporations across Europe, North America, and Japan. Its core operations encompass advanced chemical synthesis, process optimization, and large-scale production within GMP-compliant facilities. With a robust R&D infrastructure including specialized laboratories and pilot plants, the company delivers technical excellence in complex chemical processing. SCI Pharmtech maintains a strong focus on quality assurance and international regulatory compliance, positioning itself as a reliable partner for the global healthcare and life sciences sectors.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 公告本公司115年股東常會重要決議事項。 | 2026-05-22 | Chinese | |
| 公告本公司115年第一季財務合併報告董事會預計召開 日期為115年5月7日。 | 2026-04-29 | Chinese | |
| 113年8月變更登記 | 2026-04-21 | Chinese | |
| 公司基本資料 | 2026-04-21 | Chinese | |
| 115年年報及股東會資料 — 2026_4119_20260522F13.pdf | 2026-04-17 | Chinese | |
| 115年年報及股東會資料 — 2026_4119_20260522F17.pdf | 2026-04-17 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46764743 | 公告本公司115年股東常會重要決議事項。 | 2026-05-22 | Chinese | ||
| 38492599 | 公告本公司115年第一季財務合併報告董事會預計召開 日期為115年5月7日。 | 2026-04-29 | Chinese | ||
| 34696999 | 113年8月變更登記 | 2026-04-21 | Chinese | ||
| 34697023 | 公司基本資料 | 2026-04-21 | Chinese | ||
| 34655412 | 115年年報及股東會資料 — 2026_4119_20260522F13.pdf | 2026-04-17 | Chinese | ||
| 34655409 | 115年年報及股東會資料 — 2026_4119_20260522F17.pdf | 2026-04-17 | Chinese | ||
| 34655407 | 115年年報及股東會資料 — 2026_4119_20260522F02.pdf | 2026-04-17 | Chinese | ||
| 34655403 | 115年年報及股東會資料 — 2026_4119_20260522F01.pdf | 2026-04-17 | Chinese | ||
| 34644347 | 114年第4季財務報告書 — 202504_4119_AIC.pdf | 2026-04-16 | English | ||
| 34644337 | 114年第4季財務報告書 — 202504_4119_AIA.pdf | 2026-04-16 | English | ||
| 34644329 | 114年第4季財務報告書 — 202503_4119_AI1.pdf | 2026-04-16 | Chinese | ||
| 34644293 | 114年第4季財務報告書 — 202502_4119_AIA.pdf | 2026-04-16 | English | ||
| 33874334 | 115年03月內部人持股異動(事後) | 2026-04-09 | Chinese | ||
| 33874333 | 115年03月董事會成員及持股 | 2026-04-09 | Chinese | ||
| 33799524 | 115年3月背書保證與資金貸與 | 2026-04-08 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aura Biosciences, Inc.
Develops Virus-Like Drug Conjugates as targeted therapies f…
|
AURA | US | Manufacturing |
|
Aurinia Pharmaceuticals Inc.
Biopharmaceutical company developing therapies for severe a…
|
AUPH | CA | Manufacturing |
|
Aurisco Pharmaceutical Co.,Ltd.
Develops and manufactures complex APIs and intermediates wi…
|
605116 | CN | Manufacturing |
|
Aurobindo Pharma Ltd.
Vertically integrated developer and manufacturer of generic…
|
AUROPHARMA | IN | Manufacturing |
|
Auro Laboratories Ltd.
Manufactures WHO-GMP compliant APIs and intermediates, spec…
|
530233 | IN | Manufacturing |
|
Aurora Cannabis Inc.
Global producer and distributor of cannabis products for me…
|
ACB | CA | Manufacturing |
|
AURORA CANNABIS INC
Global producer and distributor of cannabis for medical and…
|
ACB | CA | Manufacturing |
|
AUTOBIO DIAGNOSTICS CO., LTD
Provides IVD solutions for immunoassay, microbiology, and m…
|
603658 | CN | Manufacturing |
|
Autolus Therapeutics plc
Biopharmaceutical company developing programmed T cell ther…
|
AUTL | GB | Manufacturing |
|
AVACTA GROUP PLC
Clinical-stage biotech developing targeted oncology drugs w…
|
AVCT | GB | Manufacturing |
SCI via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/52383/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=52383 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=52383 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=52383 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 52383}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SCI (id: 52383)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.